Skip to main content
. 2014 Dec 11;81(1):351–363. doi: 10.1128/AEM.02402-14

TABLE 2.

Primers used in this studya

Target Primer Sequence (5′→3′)
Cloning
    VP1456 (BCCT1) VP1456F (XbaI) TCTAGATCTTGTGAGTTGAAGACACTTG
VP1456R (HindIII) AAGCTTAAAAATGCCGAGCAATGAAT
    VP1723 (BCCT2) VP1723F (XbaI) TCTAGAAACTTGTGCTTGGTGATGTG
VP1723R (SacI) GAGCTCACGGCACACTTTCGCATG
    VP1905 (BCCT3) VP1905F (KpnI) GAGAGGTACCGATCTTCCGCTTTCAC
VP1905R (PstI) GAGACTGCAGAGCAGGGTGCTGGCTTC
    VPA0356 (BCCT4) VPA0356F (XbaI) TCTAGAAGCGGCTTTTTGAACATCCT
VPA0356R (HindIII) AAGCTTCCAATTAAGGGCTCTTTGCAT
SOE PCR
    VP1456 VP1456A (XbaI) TCTAGAATCAATGGGGACAGCGATAA
VP1456B cagctgagatctggtaccCGAAGCGAATTTTATCACCAA
VP1456C ggtaccagatctcagctgCGTACCGAACTTTCCGCTTA
VP1456D (SacI) GAGCTCCAACCATTTTCGCGTTTGTTC
VP1456FL-F GTCGATTACAATGGCGGATT
VP1456FL-R GTGGCACATTGTGAATGCTC
    VP1723 VP1723A (XbaI) TCTAGAACGATATGGTCTGCCAGCTT
VP1723B cagctgagatctggtaccGGGACGTTTAATCCCACCAT
VP1723C ggtaccagatctcagctgGGTCTAATGGATGAACCTCGTC
VP1723D (SacI) GAGCTCCCAATTTCTGGATAAAGCACCC
VP1273FL-F TGCGCTTTTAAACACCATTG
VP11723FL-R ATGTCCAACGGAGGACAATC
    VP1905 VP1905A (XbaI) TCTAGAGAGGAACGATGACAAAGGGTA
VP1905B cagctgagatctggtaccCGAGCCAAGACATGAATGAA
VP1905C ggtaccagatctcagctgATGTTTGATGTGCTGCCATTT
VP1905D (SacI) GAGCTCTTGATCGATTATTGACGCTCTG
VP1905FL-F AATAGCGCGGATGATCTGAC
VP1905FL-R TTGAATGCGCTTGCAATATC
    VPA0356 VPA0356A (XbaI) TCTAGACTTGATGTGAGGGGAAATGC
VPA0356B cagctgagatctggtaccTGTGTCGATGTCTGGTTTCG
VP0356C ggtaccagatctcagctgATCATTTCGGTGCTGTTCTTG
VP0356D (SacI) GAGCTCTTTGCATTTTATGGGGTTGG
VPA0356FL-F GCCCACTTCAAACTGTCGTT
VPA0356FL-R CTCGATTCGATGTCATTCCA
    VP1456 VP1456RT-F GTTCGGTCTTGCGACTTCTC
VP1456RT-R CCCATCGCAGTATCAAAGGT
    VP1723 VP1723RT-F AACAAAGGGTTGCCACTGAC
VP1723RT-R TTCAAACCTGTTGCTGCTTG
    VP1905 VP1905RT-F TGGACGGTATTCTACTGGGC
VP1905RT-R CGCCTAACTCGCCTACTTTG
    VPA0356 VPA0356RT-F CAAGGCGTAGGCCGCATGGT
VPA0356RT-R ACCGCCCACGATGCTGAACC
    VPr001 (16S rRNA) VPr001RT-F ACCGCCTGGGGAGTACGGTC
VPr001RT-R TTGCGCTCGTTGCGGGACTT
a

Underlining indicates restriction enzyme sites; nucleotides in lowercase type indicate complementary overlaps. Abbreviations: F, forward; R, reverse; RT, reverse transcriptase; FL, flanking.